» Articles » PMID: 34662187

The Role of Mutations in Seesaw Effect of Daptomycin-Resistant Methicillin-Resistant Staphylococcus Aureus Isolates

Overview
Specialty Pharmacology
Date 2021 Oct 18
PMID 34662187
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The emergence of daptomycin-resistant (DAP-R) Staphylococcus aureus strains has become a global problem. Point mutations in are the main cause of daptomycin (DAP) treatment failure. However, the impact of these specific point mutations in methicillin-resistant S. aureus (MRSA) strains associated with DAP resistance and the "seesaw effect" of distinct beta-lactams remains unclear. In this study, we used three series of clinical MRSA strains with three distinct mutated alleles from clone complexes (CC) 5 and 59 to explore the seesaw effect and the combined effect of DAP plus beta-lactams. Through construction of deletion and complementation strains of SA268, we determined that -S295A, -S337L, and one novel mutation of I348del within the bifunctional domain lead to DAP resistance. Compared with wild-type cloned from a DAP-susceptible (DAP-S) strain, these three mutations conferred the seesaw effect to distinct beta-lactams in the SA268Δ strains, and mutated (I348del and S337L) did not alter the cell surface positive charge (0.05). The susceptibility to beta-lactams increased significantly in DAP-R CC59 strains, and the seesaw effect was found to be associated with distinct mutated alleles and the category of beta-lactams. The synergistic activity of DAP plus oxacillin was detected in all DAP-R MRSA strains. Continued progress in understanding the mechanism of restoring susceptibility to beta-lactam antibiotics mediated by the mutation and its impact on beta-lactam combination therapy will provide fundamental insights into treatment of MRSA infections.

Citing Articles

Navigating collateral sensitivity: insights into the mechanisms and applications of antibiotic resistance trade-offs.

Mahmud H, Wakeman C Front Microbiol. 2024; 15:1478789.

PMID: 39512935 PMC: 11540712. DOI: 10.3389/fmicb.2024.1478789.


ESKAPE in China: epidemiology and characteristics of antibiotic resistance.

Luo Q, Lu P, Chen Y, Shen P, Zheng B, Ji J Emerg Microbes Infect. 2024; 13(1):2317915.

PMID: 38356197 PMC: 10896150. DOI: 10.1080/22221751.2024.2317915.


Antibiotic Resistance to Molecules Commonly Prescribed for the Treatment of Antibiotic-Resistant Gram-Positive Pathogens: What Is Relevant for the Clinician?.

Tebano G, Zaghi I, Baldasso F, Calgarini C, Capozzi R, Salvadori C Pathogens. 2024; 13(1).

PMID: 38276161 PMC: 10819222. DOI: 10.3390/pathogens13010088.


Small Molecules Incorporating Privileged Amidine Moiety as Potential Hits Combating Antibiotic-Resistant Bacteria.

El-Sayed S, Ahmed S, Gulia K, Lenhard J, Hassan A, Farahat A Pharmaceuticals (Basel). 2023; 16(7).

PMID: 37513951 PMC: 10384254. DOI: 10.3390/ph16071040.


Alteration of Contributes to Tigecycline Resistance and Collateral Sensitivity to Sulbactam in Acinetobacter baumannii.

Yang Y, Liu X, Zhou D, He J, Chen Q, Xu Q Microbiol Spectr. 2023; 11(3):e0459422.

PMID: 37184390 PMC: 10269438. DOI: 10.1128/spectrum.04594-22.


References
1.
Steenbergen J, Mohr J, Thorne G . Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies. J Antimicrob Chemother. 2009; 64(6):1130-8. DOI: 10.1093/jac/dkp346. View

2.
Werth B, Sakoulas G, Rose W, Pogliano J, Tewhey R, Rybak M . Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model. Antimicrob Agents Chemother. 2012; 57(1):66-73. PMC: 3535972. DOI: 10.1128/AAC.01586-12. View

3.
Peschel A, Gotz F . Analysis of the Staphylococcus epidermidis genes epiF, -E, and -G involved in epidermin immunity. J Bacteriol. 1996; 178(2):531-6. PMC: 177688. DOI: 10.1128/jb.178.2.531-536.1996. View

4.
Duss F, Garcia de la Maria C, Croxatto A, Giulieri S, Lamoth F, Manuel O . Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report. J Antimicrob Chemother. 2019; 74(9):2626-2630. DOI: 10.1093/jac/dkz253. View

5.
Ji S, Jiang S, Wei X, Sun L, Wang H, Zhao F . In-Host Evolution of Daptomycin Resistance and Heteroresistance in Methicillin-Resistant Staphylococcus aureus Strains From Three Endocarditis Patients. J Infect Dis. 2020; 221(Suppl 2):S243-S252. DOI: 10.1093/infdis/jiz571. View